July 22, US Health Care - Last Week Fact Sheets

July 22, US Health Care - Last Week Fact Sheets

Last week the following drugs were FDA approved:

No alt text provided for this image

SARCLISA is a CD38-directed cytolytic antibody indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies

including lenalidomide and a proteasome inhibitor.  Biologic License Application (BLA): 761113 Company: SANOFI AVENTIS US 

BAVENCIO is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). (1) This indication is approved under accelerated approval. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Biologic License Application (BLA): 761049 Company: EMD SERONO INC 

BAVENCIO is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). (1) This indication is approved under accelerated approval. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Biologic License Application (BLA): 761049 Company: EMD SERONO INC 

CLOLAR For Intravenous Infusion (CLOLAR; clofarabine) contains clofarabine, a purine nucleoside anti-metabolite. Clofarabine is cytotoxic to rapidly proliferating and quiescent cancer cell types in vitro. New Drug Application (NDA): 021673 Company: GENZYME

HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA (adalimumab) For the treatment of SERIOUS INFECTIONS AND MALIGNANCY Biologic License Application (BLA): 761071 Company: SANDOZ INC

Last week the following trademarks got under “Published for Opposition” stage:

No alt text provided for this image

CALROY HEALTH SCIENCES - Dietary food supplements; Dietary supplements; Food supplements; Nutraceuticals for use as a dietary supplement; Nutritional supplements.

SLEEPFINDERS - Providing health information; Providing information in the fields of health and wellness; Providing medical information; Providing medical information in the field of insomnia and other sleep disorders; Providing medical information via a website.

THERANOS - Laboratory services, namely, medical testing for diagnostic and treatment purposes; health care services; health care services in the nature of wellness programs; consulting services in the field of health and wellness.

ALLERGY OUT - Allergy medications; Allergy relief medication; Pharmaceutical preparations for treating allergies.

BIOLINE - Charge coupled device (CCD), complementary metal oxide semiconductor (CMOS) imaging sensors and cameras, all for the life sciences research industry; Charge coupled device (CCD), complementary metal oxide semiconductor (CMOS) imaging sensors and cameras not for medical purposes, all for the life sciences industry.

KNOW MORE. STRESS LESS. - Health monitors comprising alert sensors with integrated voice-activated communication technology that monitor and track the health and activity of the elderly or disabled in their own homes or in independent or assisted living facilities


NEW IPOs:

No alt text provided for this image

Intelligent Living Application Group Inc.

ILAG

"Our mission is to make life safer and smarter by designing and producing affordable, high-quality locksets and smart security systems..."

AMTD Digital Inc.

HKD

"Our mission is to act as a fusion reactor for the best entrepreneurs and innovative ideas, fusing synergistically all elements within the AMTD SpiderNet ecosystem using digital means, harnessing and magnifying the power from each partner to create a force with meaningful and influential social, technological, and economic impact..."


YUKAI Health Group Ltd

"We believe we are an expert in managing and maintaining mission-critical, regulated, reusable medical devices..."


Hesperos, Inc

HESP

"Hesperos, Inc., operating as a Contract Research Organization (“CRO”) has developed a disruptive technology that provides safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries for drug discovery and development using its Human-on-a-Chip® multi-organ, microphysiological system..."

Last week the following selective applications are “patent pending” by USPTO

SELECTIVE

No alt text provided for this image

20220232187 An imaging device according to the present disclosure includes an imaging unit, a connector, and a converter. The imaging unit includes a first signal line, a first pixel, a second signal line, and a second pixel. The first pixel outputs a first pixel voltage to the first signal line. The first pixel voltage corresponds to an amount of received light. The second pixel outputs a second pixel voltage to the second signal line. SONY SEMICONDUCTOR SOLUTIONS CORPORATION Kanagawa, JP

20220231984 SOCIAL PLATFORM WITH ENHANCED PRIVACY AND INTEGRATED CUSTOMIZATION FEATURES Embodiments provide a social networking platform offering various services, such as, facilitating aggregation and management of a user's interaction on one or more social networking platforms, offering enhanced control over the level of privacy associated with the flow of user data, offering tools to customize the user's exposure to advertisement-related content on the social networking platform(s), integrating features to control aspects of how data/content is presented to and visualized by the user, empowering the user to multicast direct messages to other users without the other users having to meet certain constraints, empowering the user to create and/or join a group based on messaging threads, and the like. SGROUPLES, INC Mountain View, CA

20220230742 MEDICAL DEVICE MANAGEMENT  A system for prioritizing patient information associated with one or more patients of a plurality of patients receiving treatment via respective devices of a plurality of medical devices, the system comprising memory and one or more processors coupled to the memory. The one or more processors are configured to receive patient information from each medical device of the plurality of medical devices and select the patient information from a subset of the plurality of medical devices based on one or more importance attributes associated with the patient information.  Medtronic, Inc. Minneapolis, MN

20220230747 HEALTH TESTING AND DIAGNOSTICS PLATFORM Systems and methods for providing a universal platform for at-home health testing and diagnostics are provided herein. In particular, a health testing and diagnostic platform is provided to connect medical providers with patients and to generate a unique, private testing environment. In some embodiments, the testing environment may facilitate administration of a medical test to a patient with the guidance of a proctor. EMED LABS, LLC Miami, FL

20220230738 REAL-TIME ANALYSIS OF COMPREHENSIVE COST OF ALL INSTRUMENTATION USED IN SURGERY UTILIZING DATA FLUIDITY TO TRACK INSTRUMENTS THROUGH STOCKING AND IN-HOUSE PROCESSES Various systems and methods for tracking surgical procedure costs are disclosed. A computer system, such as surgical hub, is configured to be communicably coupled to a plurality of surgical devices. The computer system can be programmed to identify the surgical devices that are being utilized during a surgical procedure via perioperative data received from the surgical devices and then calculate the total cost associated with the surgical devices used in the surgical procedure. The total cost can include an aggregation of the maintenance costs of each of the reusable surgical devices and the replacement costs of the nonreusable surgical devices consumed during the surgical procedure.  Cilag GmbH International ZUG, CH

20220230734 SYSTEMS AND METHODS FOR PROCESSING ELECTRONIC IMAGES FOR GENERALIZED DISEASE DETECTION Systems and methods are disclosed for generating a specialized machine learning model by receiving a generalized machine learning model generated by processing a plurality of first training images to predict at least one cancer characteristic, receiving a plurality of second training images, the first training images and the second training images include images of tissue specimens and/or images algorithmically generated to replicate tissue specimens, receiving a plurality of target specialized attributes related to a respective second training image of the plurality of second training images, generating a specialized machine learning model by modifying the generalized machine learning model based on the plurality of second training images and the target specialized attributes, receiving a target image corresponding to a target specimen, applying the specialized machine learning model to the target image to determine at least one characteristic of the target image, and outputting the characteristic of the target image. PAIGE.AI, Inc New York, NY

20220230722 SYSTEM AND METHOD FOR GENERATING AN OCULAR DYSFUNCTION NOURISHMENT PROGRAM A system and method for generating an ocular dysfunction profile outcome is presented. The system comprising a computing device configured to determine an ocular assessment as a function of receiving an ocular attribute datum, generate an ocular profile as a function of the ocular assessment, identify at least an edible as a function of the ocular profile, a nourishment composition, and an edible classifier, and develop a profile outcome including a treatment outcome and a prevention outcome as a function of the edible. KPN INNOVATIONS, LLC. Lakewood, CO

20220230718 HEALTHCARE APPLICATION INSIGHT VELOCITY AID Aspects of the invention include receiving, by a processor, medical data associated with a patient, populating a patient ontology for the patient with the medical data, determining completeness of the patient ontology for the patient based at least in part on the medical data, querying an upstream data source based on the completeness of the patient ontology, updating the patient ontology based on a query response from the upstream data source, analyzing the updated patient ontology to determine insight for the patient, and enacting an action based on the insight for the patient. International Business Machines Corporation Armonk, NY

To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics